Gibson Dunn & Crutcher

Internationally known for its financial and corporate practice, full-service firm Gibson Dunn & Crutcher offers life sciences companies deep expertise handling complex transactions. The firm is particularly renowned for its corporate and M&A practices.

Financial and corporate star Ryan Murr is co-chair of the firm's life sciences practice group. One peer notes Murr is "very well respected" in the space and is "strong in capital markets and early stage capital" matters. In addition to transactions and financing, Murr also assists clients with licensing and collaboration agreements. In the past year, Murr represented Ultragenyx in its $320 million sale of future royalties of its Crysvita® product to Royalty Pharma. In addition, Murr advised several life sciences companies with their IPO’s, including Heron Therapeutics and Odonate Therapeutics.

Another star at the firm is Joseph Barbeau, who is widely recognized in the M&A space. Operating from both the firm's Beijing and Palo Alto offices, Barbeau handles a number of domestic and international life science transactions.

Karen Spindler is a perennial LMG Life Sciences star who recently joined Gibson Dunn from Goodwin Procter, strengthening the firm’s licensing and collaboration abilities.

Gibson Dunn & Crutcher is ranked nationally for its strength in general patent litigation, supported by a group of seasoned trial lawyers with life sciences expertise. The firm is also notable for its Hatch-Waxman practice representing branded drug makers.

Jane Love is one of the firm's leading patent trial lawyers, and was shortlisted in 2020 for the Branded Hatch-Waxman Litigator of the Year award by LMG Life Sciences. She and New York partner Robert Trenchard recently acted for Novartis in a noteworthy district court matter involving the client’s $2 billion drug Gilenya. The team was successful in moving for preliminary injunction, and won a subsequent appeal.

Wayne Barsky is co-chair of the firm's IP practice group, whose current focus involves a patent infringement suit for Amgen against Coherus related to the client’s large molecule drug Amgevita. Life sciences group co-chair Tracey Davies represented Natera against Illumina in a Northern District of California suit involving prenatal testing patents. In other matters, Davies is acting for Sanofi in five Hatch-Waxman suits concerning its insulin products.

The firm recently hired Joshua Lerner from Durie Tangri. He is well-versed in life sciences patent litigation, and has in-house experience as former senior litigation counsel at a major life sciences company.

International firm Gibson Dunn & Crutcher earns top-tier status in the antitrust and white-collar areas, with an additional recognition for product liability.

Based in the firm’s Orange County office, Jeffrey Thomas has dual expertise in litigation related to antitrust and intellectual property. He recently represented Amgen in an antitrust litigation filed by Cipla, derived from a settlement of a patent infringement dispute between the client and Teva. The matter is currently pending.

San Francisco partner Winston Chan supports the firm's reputation as a go-to firm for government investigations. He has deep experience in matters related to the False Claims Act, Foreign Corrupt Practices Act and Anti-Kickback Statute. Reed Brodsky is co-chair of the firm’s crisis management practice group and a member of the government investigations department. He is a trial lawyer well-versed in matters related to securities, compliance counseling, internal investigations and commercial disputes.